Welcome
Support Centre
12 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
A pilot study of stenting of autologous saphenous vein on early graft remodelling after coronary artery bypass surgery
Source of recordUK Trials
ISRCTNISRCTN77486578
Date ISRCTN assigned29/10/2001
Local reference number(s)PG/96147
Public titleA pilot study of stenting of autologous saphenous vein on early graft remodelling after coronary artery bypass surgery
Scientific title
AcronymEXTENT-1
Disease/condition/study domainPrevention of saphenous vein graft stenosis by the use of an external stent
Study hypothesisBrief summary:
Bypass grafting using leg veins is a very effective surgical treatment for advanced coronary heart disease, although the initial benefits of the operation tend to be lost over the following years. This is because the vein grafts themselves become blocked like the original coronary arteries. Many attempts have been made to prevent these late failures either by variations in surgical technique or by using drugs, however the problem remains. Based on a British Heart Foundation funded collaboration between basic scientists and cardiac surgeons stretching over the past 10 years, a radically new therapy has been devised. This involves wrapping the vein in a stocking-like material during the bypass operation so that it will be continuously supported during its life as a graft. In experimental studies,this has had a dramatic effect in reducing the thickening of the graft wall. The present project will be the first test of the effectiveness of the new technique in man.

Hypothesis:
Application of a highly porous non-restrictive external stent to autologous saphenous veins at the time of implantation of coronary artery bypass grafts will reduce graft thickening and neointima formation and increase lumen size.
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteriaPatients undergoing coronary artery bypass surgery
Participants - exclusion criteriaRe-do surgery, first CABG with an associated procedure, associated valve disease, recent MI (<1 month), poor ejection fraction (<30%), diabetes, previous history of inflammatory disease and unwillingness to participate in follow-up.
Patient information material
Anticipated start date01/03/2005
Anticipated end date30/03/2007
Status of trialCompleted
Target number of participants40
Interventions1. One group of patients will receive conventional bypass graft surgery with saphenous vein
2. In the second group the saphenous vein will be supported with a polyester made stent
Primary outcome measure(s)Study endpoints: Graft wall thickness and luminal size using intravascular ultrasound (IVUS) at time of operation and at follow-up. Wall and luminal volume will be computed from the 3-D reconstructions and compared to values obtained intraoperatively. Final wall and luminal volumes and the changes in these parameters will be compared in stented and unstented grafts. Angiography will be carried out as a necessary adjunct to intravascular ultrasound at follow-up.

Clinical Outcomes: Adverse clinical events, including death, myocardial infarction, bleeding, infections, need for reoperation, recurrence of
symptoms will be recorded.
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingBritish Heart Foundation (PG/96147)
Sponsor nameBritish Heart Foundation (UK)
Sponsor details14 Fitzhardinge Street
London
United Kingdom
W1H 6DH
Sponsor telephone+44 (0)20 7935 0185
Sponsor fax+44 (0)20 7486 5820
Sponsor emailresearch@bhf.org.uk
Sponsor websitehttp://www.bhf.org.uk/
Contact nameProf Gianni Angelini
Contact detailsDepartment of Cardiac Surgery
United Bristol Healthcare Trust
Bristol Heart Institute
Bristol Royal Infirmary
Marlborough Street
Bristol
United Kingdom
BS2 8HW
Contact telephone+44 (0)117 928 3145
Contact fax+44 (0)117 929 9737
Contact emailG.D.Angelini@bristol.ac.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN77486578
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central